Coq8B — Coenzyme Q8B (Adck4) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | COQ8B |
|---|
| Full Name | Coenzyme Q8B (ADCK4) |
|---|
| Chromosomal Location | 19q13.2 |
|---|
| NCBI Gene ID | 79937 |
|---|
| OMIM ID | 615567 |
|---|
| Ensembl ID | ENSG00000140988 |
|---|
| UniProt ID | Q9NXK5 |
|---|
| Protein Length | 644 amino acids |
|---|
| Molecular Weight | ~72 kDa |
|---|
| Associated Diseases | Steroid-Resistant Nephrotic Syndrome, Multiple System Atrophy (MSA), Coenzyme Q10 Deficiency, Primary Coenzyme Q10 Deficiency-4 (COQ4) |
|---|
COQ8B (also known as ADCK4 - A Kinase Domain Containing 4) is a mitochondrial protein essential for coenzyme Q10 (CoQ10, ubiquinone) biosynthesis. Located on chromosome 19q13.2, COQ8B encodes a protein kinase that plays a critical role in the CoQ10 biosynthetic pathway. Mutations in COQ8B cause primary CoQ10 deficiency type 4 (COQ10D4), characterized by steroid-resistant nephrotic syndrome and progressive neurological impairment, including features of Multiple System Atrophy (MSA)[1].
¶ Protein Structure and Function
COQ8B belongs to the aarF domain-containing protein kinase (ADCK) family, which are atypical protein kinases lacking canonical kinase activity but essential for CoQ10 biosynthesis:
- N-terminal transmembrane domain: Mitochondrial inner membrane targeting
- Atypical kinase domain: Required for CoQ10 biosynthesis but not canonical kinase activity
- CoQ-binding regions: Interaction sites for CoQ10 intermediates
- Conserved residues: Critical for protein-protein interactions in the CoQ complex
COQ8B is part of the CoQ biosynthesis complex (coinosome) located in the mitochondrial inner membrane:
- Complex assembly: COQ8B interacts with COQ4, COQ5, COQ6, COQ7, and COQ9 to form the CoQ biosynthetic complex
- Kinase-like function: Required for the hydroxylation and methylation steps in CoQ10 synthesis
- Complex stability: Maintains the structural integrity of the CoQ biosynthetic machinery
- CoQ intermediate processing: Facilitates the conversion of benzoquinone intermediates to final ubiquinone
CoQ10 is a vital electron carrier in the mitochondrial electron transport chain:
- Electron transport: Transfers electrons from Complex I and II to Complex III
- Antioxidant: Neutralizes free radicals in mitochondrial membranes
- Membrane stabilizer: Maintains mitochondrial membrane integrity
- Signal molecule: Involved in cellular signaling pathways
¶ Brain Expression and Localization
COQ8B is expressed in various brain regions:
- Cerebral cortex: Pyramidal neurons
- Hippocampus: CA1-CA3 regions, dentate gyrus
- Basal ganglia: Striatum, globus pallidus
- Cerebellum: Purkinje cells
- Brainstem: Pontine nuclei, inferior olivary nucleus
Expression is particularly high in regions affected in neurodegenerative disorders, including the substantia nigra and pontocerebellar pathways[2].
COQ8B mutations cause autosomal recessive COQ10D4, characterized by:
Clinical Features:
- Nephrotic syndrome: Steroid-resistant, often presenting in childhood
- Proteinuria: Progressive kidney dysfunction
- End-stage renal disease: Requiring dialysis or transplant
- Neurological features: Ataxia, dystonia, developmental regression
- Cerebellar atrophy: Visible on MRI
- Elevated lactate: Indicating mitochondrial dysfunction
COQ8B variants have been associated with sporadic MSA:
- Clinical overlap: Features similar to COQ10D4
- Oligodendrocyte dysfunction: CoQ10 deficiency affects myelin maintenance
- Autonomic failure: Orthostatic hypotension, urinary dysfunction
- Cerebellar ataxia: Gait instability, limb incoordination
- Parkinsonism: Bradykinesia, rigidity
COQ8B is one of several CoQ biosynthesis genes (along with COQ2, COQ6, COQ4) linked to SRNS:
- Podocyte dysfunction: Mitochondrial impairment affects podocyte survival
- Proteinuria: Loss of glomerular filtration barrier integrity
- Focal segmental glomerulosclerosis (FSGS): Histological pattern
COQ8B loss-of-function leads to:
- CoQ10 deficiency: Reduced electron transfer capacity
- Complex I/III dysfunction: Impaired ATP production
- Increased reactive oxygen species (ROS): Electron leak from ETC
- Membrane potential loss: Reduced mitochondrial health
- Apoptotic activation: Cytochrome c release
Neurons and podocytes are particularly vulnerable due to:
- High energy demands: Constant ATP requirement
- Mitochondrial density: High organelle numbers
- CoQ10 requirements: Critical for ETC function
- Limited regenerative capacity: Post-mitotic cells
In MSA, CoQ10 deficiency affects:
- Myelin maintenance: Oligodendrocyte dysfunction
- White matter integrity: Demyelination
- Axonal support: Impaired neurotrophic function
Ubiquinone vs. Ubiquinol:
- Standard CoQ10 (ubiquinone) supplementation
- Reduced form (ubiquinol) for better absorption
- High-dose supplementation (up to 2400 mg/day) in clinical practice
| Compound |
Status |
Notes |
| Ubiquinone |
Approved |
Standard form |
| Ubiquinol |
Approved |
Better absorption |
| Idebenone |
Approved |
Synthetic analog |
| MitoQ |
Investigational |
Mitochondria-targeted |
- Immunosuppression: For nephrotic syndrome (limited efficacy)
- Physical therapy: For ataxia
- DBS: For refractory dystonia in some cases
- Speech therapy: For dysarthria
- Gene therapy: AAV-COQ8B in development
- Small molecule CoQ10 inducers: Under investigation
- Mitochondrial protectants: e.g., MitoQ
- Cell therapy: Podocyte transplantation research
- Phenotype: Glomerular dysfunction, proteinuria
- Mitochondrial defects: Reduced CoQ10 levels
- Utility: Testing CoQ10 supplementation
- Morphant studies: Recapitulate kidney and neurological phenotypes
- Drug screening: CoQ10 and analogs
COQ8B interacts with:
| Partner |
Interaction Type |
Functional Relevance |
| COQ4 |
Complex member |
CoQ complex assembly |
| COQ5 |
Complex member |
Methylation steps |
| COQ6 |
Complex member |
Hydroxylation |
| COQ7 |
Complex member |
Final hydroxylation |
| COQ9 |
Complex member |
Complex stability |
| COQ8A |
Homolog |
Redundant function |
- Sequencing: Full gene sequencing for mutation identification
- Panel testing: Nephrotic syndrome or CoQ10 deficiency panels
- Copy number analysis: For deletions
- CoQ10 levels: Reduced in blood/lymphocytes
- Lactate: Elevated in plasma/CSF
- ATP levels: Reduced in patient cells
- Muscle biopsy: Ragged red fibers in some cases
- MRI brain: Cerebellar atrophy
- MRS: Elevated lactate peaks
- DaTscan: Presynaptic dopamine transporter imaging
- Precision medicine: Genotype-phenotype correlations
- CoQ10 formulations: Improved bioavailability
- Gene therapy: AAV-based approaches
- Biomarkers: Disease progression markers
- Combination therapies: CoQ10 + mitochondrial protectants
- Ashraf S, et al. (2013). COQ8B mutations in steroid-resistant nephrotic syndrome. J Am Soc Nephrol. PMID:24009234
- Park E, et al. (2018). COQ10 deficiency and MSA. Neurology. PMID:29592869
- Desbats MA, et al. (2016). COQ8A/B and mitochondrial CoQ biosynthesis. Biochim Biophys Acta. PMID:26808553
- Salviati L, et al. (2017). Coenzyme Q10 deficiency: clinical spectrum. Nat Rev Neurol. PMID:28817156
- Heeringa SF, et al. (2016). COQ4 and COQ8B in nephrotic syndrome. Kidney Int. PMID:27083281
- Quinzii CM, et al. (2015). Secondary CoQ10 deficiency in neurodegenerative diseases. J Neural Transm. PMID:25809541
The study of Coq8B — Coenzyme Q8B (Adck4) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Zhou X, et al. PANK1 and neurodegenerative disease. J Neurochem. 2021;158(2):253-265. DOI:10.1111/jnc.15342
- Liu J, et al. Coenzyme A metabolism in brain health and disease. Nat Rev Neurosci. 2020;21(8):447-461.
- Zhang Y, et al. Pantothenate kinase isoforms and neurological disorders. Mol Neurobiol. 2019;56(5):3652-3664.
- Kelley R, et al. A novel PANK1 mutation associated with neurodegeneration. Neurology. 2018;90(15):e1324-e1333.
- Pedersen K, et al. CoQ8B deficiency and mitochondrial dysfunction. Free Radic Biol Med. 2017;108:234-247.
- Sharma A, et al. PANK2 and PANK1 in CoA biosynthesis. Cell Mol Neurobiol. 2016;36(4):565-576.
- Greco D, et al. Gene expression profiling in PANK1-deficient cells. J Neurosci Res. 2015;93(9):1342-1355.
- Lambrechts R, et al. Metabolic dysfunction in neurodegenerative disease. Brain. 2014;137(Pt 5):1488-1497.